Bladder benign neoplasm

Summary

Bladder benign neoplasm (MONDO:0000384) is a cancer. A subtype of benign urinary system neoplasm — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Classification: Cancer

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	bladder benign neoplasm
Mondo ID	MONDO:0000384
DOID	DOID:0050623
ICD-10-CM	D30.3
ICD-11	750827946
NCIT	C3618
SNOMED CT	91992005
UMLS	C0154017
MedGen	57811
Anatomy (UBERON)	UBERON:0001255
Is cancer (heuristic)	yes

Also known as: benign bladder neoplasm · benign bladder tumor · benign bladder tumour · benign neoplasm of bladder · benign neoplasm of the bladder · benign neoplasm of the urinary bladder · benign neoplasm of urinary bladder · benign tumor of bladder · benign tumor of the bladder · benign tumor of the urinary bladder · benign tumor of urinary bladder · benign tumour of bladder · benign tumour of the bladder · benign tumour of the urinary bladder · benign tumour of urinary bladder · benign urinary bladder neoplasm · benign urinary bladder tumor · benign urinary bladder tumour · urinary bladder benign neoplasm

Disease family

This is a subtype of benign urinary system neoplasm. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › cancer or benign tumor › neoplastic disease or syndrome › neoplasm › benign neoplasm › benign urinary system neoplasm › bladder benign neoplasm

Related subtypes (5): ureter benign neoplasm, benign prostate phyllodes tumor, kidney benign neoplasm, urothelial papilloma, benign urethral neoplasm

Subtypes (4): bladder leiomyoma, bladder squamous papilloma, nephrogenic adenoma of urinary bladder, bladder urothelial papilloma

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.